What is Regeneron Pharmaceuticals's restricted cash?

Regeneron Pharmaceuticals (REGN) reported restricted cash of $8M in Q1 2026.

How has Regeneron Pharmaceuticals's restricted cash changed year-over-year?

Regeneron Pharmaceuticals's restricted cash increased by 185.7% year-over-year, from $2.8M to $8M.

What does restricted cash mean?

Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.

Regeneron Pharmaceuticals REGN Restricted Cash

Restricted Cash at other companies

Merck & Co.MRK

$71M-31.1%

GlaukosGKOS

$3.83M-19.0%

EyePoint, Inc. EYPT

$150K0.0%

Ocular TherapeutixOCUL

$1.61M0.0%

Kodiak Sciences IncKOD

$6.18M0.0%

AnnexonANNX

$1.03M0.0%

Other financials

Income statement

See full

Revenue$3.6B+19.0%

Operating income$642.9M+8.7%

Net income$727.2M-10.1%

EPS (diluted)$6.75-7.2%

Balance sheet

See full

Cash & equivalents$3.0B-4.0%

Total debt$2.7B+0.1%

Total equity$31.4B+6.9%

Total assets$40.9B+8.9%

Cash flow

See full

Operating cash flow$1.1B+3.2%

CapEx$230.6M+0.6%

Free cash flow$848.3M+4.0%

Valuation

See full

Market cap$65.37B+21.9%

Enterprise value$65.11B+20.0%

P/E14.8×+2.8×

P/S4.4×+0.6×

Profitability

See full

Gross margin93.9%—

Operating margin24.3%-2.9pp

Net margin29.6%-2.3pp

FCF margin27.6%+5.5pp

Returns & leverage

See full

Return on equity14.5%-1.4pp

Debt / equity0.1×0.0×

Current ratio3.6×-1.4×

Where this comes from

Reported directly by Regeneron Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:RestrictedCashCurrent.

The official record: Regeneron Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Regeneron Pharmaceuticals's restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Regeneron Pharmaceuticals's restricted cash?: Regeneron Pharmaceuticals (REGN) reported restricted cash of $8M in Q1 2026.
How has Regeneron Pharmaceuticals's restricted cash changed year-over-year?: Regeneron Pharmaceuticals's restricted cash increased by 185.7% year-over-year, from $2.8M to $8M.
What does restricted cash mean?: Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.